EMAIL THIS PAGE TO A FRIEND

PloS one

CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies.


PMID 23139769

Abstract

Previous reports implicate CYP2E1 RsaI/PstI polymorphism as a possible risk factor for several cancers. Published studies on the relationship of CYP2E1 RsaI/PstI polymorphisms with the susceptibility to gastric cancer are controversial. This study aimed to determine this relationship accurately. Meta-analyses that assessed the association of CYP2E1 RsaI/PstI variations with gastric cancer were conducted. Subgroup analyses on ethnicity, smoking status, alcohol consumption, and source of controls were also performed. Eligible studies up to Mar 2012 were identified. After rigorous searching and screening, 24 case-control studies comprising 3022 cases and 4635 controls were selected for analysis. The overall data failed to indicate the significant associations of CYP2E1 RsaI/PstI polymorphisms with the gastric cancer risk [c2 vs. c1: odds ratio (OR) =1.06; 95% confidence interval (CI) =0.88-1.28; c2c2 vs. c1c1: OR=1.23; 95% CI=0.78-1.92; c2c2+c1c2 vs. c1c1: OR=0.93; 95% CI=0.79-1.10]. Similar results were observed in the subgroup analyses on ethnicity, drinking status, and source of controls. However, in the subgroup analysis on smoking status, a borderline increase in cancer risk was found among long-term smokers (c2c2+c1c2 vs. c1c1: OR=1.39; 95% CI=1.00-1.92). CYP2E1 RsaI/PstI polymorphisms may modify the susceptibility to gastric cancer among individuals who have a smoking history. Large and well-designed studies are needed to confirm this conclusion.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

R6142 Acc I from Acinetobacter calcoaceticus, Restriction Enzyme
R6885 Alu I from Arthrobacter luteus, Restriction Enzyme
R4258 Apa I from Acetobacter pasteurianus, Restriction Enzyme
R0260
BamH I from Bacillus amyloliquefaciens H, Restriction Enzyme
R8631
Bcl I from Bacillus caldolyticus, Restriction Enzyme
R6377
Bgl II from Bacillus licheniformis, Restriction Enzyme
R3131
Bln I from Brevibacterium linens, buffered aqueous glycerol solution
R3635
Bsm I from Bacillus stearothermophilus NUB 36, Restriction Enzyme
R4253 BstE II from Bacillus stearothermophilus ET, Restriction Enzyme
R1761
Cfo I from Clostridium formicoaceticum, Restriction Enzyme
R7763
Cla I from Caryophanon latum L, Restriction Enzyme
R4256
Dde I from Desulfovibrio desulfuricans strain Norway, Restriction Enzyme
R8381
Dpn I from Diplococcus pneumoniae, Restriction Enzyme
R4381
Dra I from Deinococcus radiophilus, Restriction Enzyme
R3884 EclX I from Enterobacter cloacae 590, Restriction Enzyme
R6265
EcoR I from Escherichia coli BS5, Restriction Enzyme
R2756
EcoR V from Escherichia coli, buffered aqueous glycerol solution
R5628 Hae III from Haemophilus aegyptius, Restriction Enzyme
R1137 Hind III from Haemophilus influenzae, Restriction Enzyme
R8507 Hpa I from Haemophilus parainfluenzae, Restriction Enzyme
R0629 Hpa II from Haemophilus parainfluenzae, buffered aqueous glycerol solution
R4134 Ksp I from Kluyvera sp., Restriction Enzyme
R4506
Msp I from Moraxella sp., buffered aqueous glycerol solution
R1632
Mva I from Micrococcus varians Rfl 19, Restriction Enzyme
R8761 Nco I from Nocardia corallina, Restriction Enzyme
R5509
Nde I from Neisseria denitrificans, Restriction Enzyme
R5634
Nhe I from Neisseria mucosa heidelbergensis, Restriction Enzyme
R8506
Not I from Nocardia otidiscaviarum, Restriction Enzyme
R5884 Nsi I from Neisseria sicca, Restriction Enzyme
R7023
Pst I from Providencia stuartii, Restriction Enzyme